alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.13


 


October 8,
2004


 


Sunrise
Securities Corp.

641 Lexington Avenue

25th Floor

New York, New York 10022


 


Re:          International
Shipping Enterprises, Inc.


 


Gentlemen:


 


This
letter will confirm the agreement of the undersigned to purchase warrants (“Warrants”)
of International Shipping Enterprises, Inc. 
(“Company”) included in the units (“Units”) being sold in the Company’s
initial public offering (“IPO”) upon the terms and conditions set forth herein.  Each Unit is comprised of one share of
Common Stock and two Warrants.  The
shares of Common Stock and Warrants will not be separately tradeable until 90
days after the effective date of the Company’s IPO unless Sunrise Securities
Corp. (“Sunrise”) informs the Company of its decision to allow earlier separate
trading.


 


The undersigned
agrees that this letter agreement constitutes an irrevocable order for Sunrise
to purchase for the undersigned’s account within the forty-trading day period
commencing on the date separate trading of the Warrants commences (“Separation
Date”) up to 2,000,000 Warrants at market prices not to exceed $0.70 per
Warrant (“Maximum Warrant Purchase”). 
Sunrise (or such other broker dealer(s) as Sunrise may assign the order
to) agrees to fill such order in such amounts and at such times as it may
determine, in its sole discretion, during the forty-trading day period
commencing on the Separation Date. 
Sunrise further agrees that it will not charge the undersigned any fees
and/or commissions with respect to such purchase obligation.  


 


The
undersigned may notify Sunrise that all or part of the Maximum Warrant Purchase
will be made by an affiliate of the undersigned (or another person or entity
introduced to Sunrise by the undersigned (a “Designee”)) who (or which) has an
account at Sunrise and, in such event, Sunrise will make such purchase on
behalf of said affiliate or Designee; provided, however, that the undersigned
hereby agrees to make payment of the purchase price of such purchase in the
event that the affiliate or Designee fails to make such payment.  


 


The
undersigned agrees that neither she nor any affiliate or Designee shall sell or
transfer the Warrants until the earlier of the consummation of a merger,
capital stock exchange, asset acquisition or other similar business combination
or the distribution of that certain trust account established for the benefit
of the Company’s public stockholders and acknowledges that, at the option of
Sunrise, the certificates for such Warrants shall contain a legend indicating
such restriction on transferability.  


 


	
   

  	
  Very
  truly yours,

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  /s/
  Angeliki Frangou

  	
   

  
	
   

  	
  Angeliki
  Frangou
[Federal Register Volume 74, Number 100 (Wednesday, May 27, 2009)]
[Notices]
[Page 25263]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12325]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Injury Prevention and Control Initial Review 
Group (NCIPC IRG)

    Correction: This notice was published in the Federal Register on 
May 1, 2009, Volume 74, Number 83, Page 20325. The times and place for 
the aforementioned meeting for the review, discussion, and evaluation 
of individual research cooperative agreement applications submitted in 
response to Fiscal Year 2009 Requests for Applications (RFA) related to 
the following individual research announcement: RFA EH-09-002 ``Program 
to Expand State Public Health Laboratory Capacity for Newborn Bloodspot 
Screening (U01)'' has been changed to the following:

    Times and Date:

12:30 p.m.-12:45 p.m., July 9, 2009 (Open)
12:45 p.m.-2:30 p.m., July 9, 2009 (Closed)

    Place: Teleconference, Toll Free: 888-793-2154, Participant 
Passcode: 4424802.
    Contact Person for More Information: Jane Suen, Dr.P.H., M.S., 
NCIPC, CDC, 4770 Buford Highway, NE., Mailstop F-62, Atlanta, 
Georgia 30341. Telephone: (770) 488-4281.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 19, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-12325 Filed 5-26-09; 8:45 am]
BILLING CODE 4163-18-P
#### The People of the State of New York, Respondent, v James Bellman, Appellant.

[976 NYS2d 401]

Appeal by the defendant from a judgment of the Supreme Court, Nassau County (Sullivan, J.), rendered August 3, 2011, convicting him of assault in the third degree and menacing in the second degree, upon a jury verdict, and imposing sentence.

Ordered that the judgment is affirmed.

In fulfilling our responsibility to conduct an independent review of the weight of the evidence *(see*CPL 470.15 [5]; *People v Danielson,*9 NY3d 342, 348 [2007]), we nevertheless accord great deference to the jury’s opportunity to view the witnesses, hear the testimony, and observe demeanor *(see People v Mateo,*2 NY3d 383 [2004], *cert denied*542 US 946 [2004]; *People v Bleakley,*69 NY2d 490, 495 [1987]). Upon reviewing the record here, we are satisfied that the verdict of guilt was not against the weight of the evidence *(see People v Romero,*7 NY3d 633 [2006]).

The defendant’s contention that the trial court erred in denying, without a hearing, his motion to set aside the verdict due to improper juror conduct *(see*CPL 330.30 [2]) is without merit. The Supreme Court properly determined that even if the allegations were true, the alleged misconduct did not affect a *733substantial right of the defendant *(see People v Rodriguez,*100 NY2d 30, 35 [2003]; *People v Irizarry,*83 NY2d 557, 561 [1994]).

The defendant’s contention that he was deprived of a fair trial by the prosecutor’s comment in summation on his prearrest silence is unpreserved for appellate review since he failed to raise that specific objection at trial *(see*CPL 470.05 [2]; *People v Beauliere,*36 AD3d 623 [2007]; *People v Materon,*276 AD2d 718 [2000]).

The defendant’s remaining contentions are without merit. Mastro, J.E, Lott, Austin and Hinds-Radix, JJ., concur.
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

MARVIN ERICK VARGAS GARCIA,

Petitioner,

v.

MERRICK B. GARLAND, Attorney

General,

Respondent. No. 18

- 70250

Agency No. A074

- 798

- 801

MEMORANDUM *

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted July 19, 2021 * *

Before: SCHROEDER, SILVERMAN, and MURGUIA, Circuit Judges.

Marvin Erick Vargas Garcia, a native and citizen of Guatemala

, petitions for

review of the Board of Immigration Appeals’ (“BIA”) order denying his motion to

reopen and remand

. We have jurisdiction under 8 U.S.C. § 1252. We review the

* This disposition is not appropriate for publication and is not precedent

except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

JUL 23 2021

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS2 18

- 70250

BIA’s denial of a motion to reopen and remand for abuse of discretion. Movsisian

v . Ashcroft , 395 F.3d 1095, 1098 (9th Cir. 2005)

. We deny the petition for review.

The BIA did not abuse its discretion in denying Vargas Garcia’s motion to

reopen and remand based on changed country conditions where he failed to

establish prima facie eligibility for relief

. See 8 C.F.R. § 1003.2(c) (3)(ii) ; Ramirez

Munoz v. Lynch , 816 F.3d 1226, 1228 (9th Cir. 2016) (the BIA may deny a motion

to reopen for failure to establish prima facie eligibility for the relief sought) ;

Nagoulko v. INS , 333 F.3d 10 12, 1018 (9th Cir. 2003) (possibility of persecution

“too speculative”). We reject as unsupported by the record Vargas Garcia’s

contention that the agency ignored evidence, misstated the record, or otherwise

erred in its analysis of his motion

.

PETITION F OR REVIEW DENIED.
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: In re L.D.H. and J.J.R.G.

Appellate case number: 01-19-00130-CV

Trial court case number: 2015-01818J-A

Trial court: 313th District Court of Harris County

Relator, Angela Cantu, has filed an unopposed motion to abate this original 

proceeding “while the parties pursue their resolution of this case.” We grant the motion 

and abate the proceeding.

Unless the parties file, no later than July 15, 2019, a motion to reinstate and 

dismiss or otherwise dispose of relator’s petition, a motion to reinstate and proceed with 

this original proceeding, or a report advising the Court of the status of the trial court 

proceedings, this original proceeding may be reinstated and dismissed without further 

notice.

This Court’s February 26, 2019 order staying the trial court’s February 22, 2019 

order lifting “[t]he prior ‘no movement order’” and permitting the Department of Family 

and Protective Services “to place the children with relatives in Panama” continues to 

remain effective until disposition of relator’s petition for a writ of mandamus or further 

order of this Court.

The original proceeding is abated, treated as a closed case, and removed from this 

Court’s active docket. 

It is so ORDERED.

Judge’s signature: /s/ Julie Countiss

 Acting individually  Acting for the Court

Date: __April 23, 2019____
### D ISTRICT 

### C OURT 

### O F 

### APPEAL 

### O F 

### F LORIDA 

### S ECOND 

### D ISTRICT

DARRON HYMES, Appellant,
v. DALE WINDSOR, Appellee Case No. 2D21-76 September 8, 2021 Appeal from the County Court for Pasco County; Paul E. Firmani, Judge. Darron Hymes, pro se. J. Marshall Fry of J. Marshall Fry, Attorney At Law, Palm Harbor, for Appellee. PER CURIAM. Affirmed. SLEET, ATKINSON, STARGEL, JJ., Concur. Opinion subject to revision prior to official publication.
No. 840.

#### Thomson, Trustee, *v.*Boles.

February 9, 1942.

*Messrs. Warren Newcome, William T. Faricy,*and *Alfred E. Rietz*for petitioner. *Mr. Chester W. Johnson*for respondent.

Petition for writ of certiorari to the Circuit Court of Appeals for the Eighth Circuit denied.
STATE OF LOUISIANA

COURT OF APPEAL, FIRST CIRCUIT

ANGELLE ROSE SWAIN

VERSUS

FLEETWASH, INC., JAMES TRAVIS

CORTEZ, THE ESTATE OF CODY JUDE

COVEL, HAMBRON, INC., EDWARD

SMITH, ROBERT L. EMKEY, 

PROGRESSIVE INSURANCE COMPANY, 

ABC INSURANCE COMPANY, DEF

INSURANCE COMPANY, XYZ

INSURANCE COMPANY, AND DOES 1-

50

In Re: James Travis Cortez, applying

21st Judicial District Couri, 

No. 20153370. 

NO. 2022 CW 1364

MARCH 27, 2023

for supervisory writs, 

Parish of Tangipahoa, 

BEFORE: GUIDRY, C. J. , WOLFE AND MILLER',, J J. 

WRIT DENIED. 

COURT OF APPEAL, FIRST CIRCUIT

DEPUTY CLERK OF COURT

FOR THE COURT

JMG

EW

SMM
<TABLE> <S> <C>


<ARTICLE>                                            5
<MULTIPLIER>                                         1000
<PERIOD-TYPE>                                              9-MOS
<FISCAL-YEAR-END>                                    DEC-31-1997
<PERIOD-END>                                         SEP-30-1997
<CASH>                                               21,900
<SECURITIES>                                         52,500
<RECEIVABLES>                                        272,400
<ALLOWANCES>                                         8,800
<INVENTORY>                                          572,300
<CURRENT-ASSETS>                                     983,400
<PP&E>                                               4,404,800
<DEPRECIATION>                                       1,959,100
<TOTAL-ASSETS>                                       3,646,100
<CURRENT-LIABILITIES>                                409,400
<BONDS>                                              809,900
<COMMON>                                             101,900
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                           1,206,500
<TOTAL-LIABILITY-AND-EQUITY>                         3,646,100
<SALES>                                              2,311,700
<TOTAL-REVENUES>                                     2,311,700
<CGS>                                                1,732,400
<TOTAL-COSTS>                                        1,930,100
<OTHER-EXPENSES>                                     100,500
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   38,400
<INCOME-PRETAX>                                      242,700
<INCOME-TAX>                                         88,600
<INCOME-CONTINUING>                                  154,100
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      3,300
<CHANGES>                                            0
<NET-INCOME>                                         150,800
<EPS-PRIMARY>                                        1.59
<EPS-DILUTED>                                        1.59


</TABLE>
EXHIBIT
      32.2




**CERTIFICATION**


**PURSUANT
      TO 18 U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of QuantRx Biomedical Corporation (the
      "Company") on Form 10-Q for the period ending September 30, 2008 as filed with
      the Securities and Exchange Commission on the date hereof (the "Report"), I,
      Sasha Afanassiev, Chief Financial Officer of the Company, certify, pursuant
      to
      18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that to my knowledge:





1.
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and





2.
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.


/s/
                Sasha
                AfanassievSasha
                AfanassievCFO,
                Treasurer
                & VP of Finance
  Date:
        November 14, 2008





A
      signed
      original of this written statement required by Section 906 has been provided
      to
      the Company and will be retained by the Company and furnished to the Securities
      and Exchange Commission or its staff upon request.
NGA Office of the Ombudsman (NGAO)

• Work with people to facilitate equitable outcomes

• Provide a zero barrier office where it is safe to discuss workplace problems

• Help people make sense of what is happening to them, by them, and around them

• Receive serious concerns from individuals who otherwise might not come forward 

• Provide 1-to-1 conflict coaching to increase individuals competence and confidence 

to resolve workplace issues

• Identify and provide early warning to the appropriate parties about new and 

potentially disruptive problems 

• Help get responses to serious incidents requiring action

• Focus on systemic issues and conflict prevention strategies

• Increase trust, fairness, equity, and respect by fostering an ethical, values-driven 

culture

• Provide training and engagement opportunities on a full range of conflict resolution 

topics and techniques

To engage the workforce at all levels to explore non-adversarial approaches for 

resolving problems or addressing mission concerns; to develop partnerships 

across the organization in order to promote better communication, foster 

constructive dialogue, and increase collaboration; to drive the mission by 

helping to remove barriers.

Vision

Mission

What We Do

To effect positive change for people, partnerships, mission today and 

mission tomorrow by providing ombuds services to the NGA workforce and 

stakeholders.

Approved for public release, 20-371
Standards of Practice

• We listen to all perspectives and we don’t take sides

• We advocate for fairness, not individual people or positions

• We don’t hold any other positions that would create a conflict of interest

Neutral / Impartial

• We help everyone understand their options

• We don’t investigate, arbitrate, or make decisions for anyone

• We’re not an office of notice and we don’t accept formal complaints

• We can’t force anyone to take a particular course of action

• We don’t take the place of, or stop the clock on, any formal, administrative process

Informal

• We are aligned to the Director; not part of management

• We have direct access to people and information 

• We have full autonomy in all of our work

Independent

• We have broad, mandatory confidentiality protections to the extent permitted by law

• We don’t keep names or records that could identify someone

• We don’t share information or identities without permission

• We won’t testify or serve as a witness and we have a duty to resist

• These protections exclude imminent risk of harm to self or others

Confidential / Anonymous

Contact Information

ombuds@coe.ic.gov

(Secure) 578-4777

ombuds@nga.mil

(U) 571-557-4777

NCE Offices: 

N22360/N22361

NCW Office:

Building 36, BE-115

OCC 200113-035
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-END>                               MAR-30-1998
<CASH>                                              32
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                    32
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                      32
<CURRENT-LIABILITIES>                          1122312
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                     750000
<COMMON>                                        291404
<OTHER-SE>                                     3166718
<TOTAL-LIABILITY-AND-EQUITY>                        32
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 16674
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (16674)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                 (16674)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (16674)
<EPS-PRIMARY>                                   (.002)
<EPS-DILUTED>                                        0
        

</TABLE>
<PAGE>
EXHIBIT 10.5


                                AMENDMENT TO THE
                              HANOVER DIRECT, INC.
                        DIRECTORS CHANGE OF CONTROL PLAN

                               Amendment Number 1

         WHEREAS, Hanover Direct, Inc. (the "Company") maintains the Hanover
Direct, Inc. Directors Change of Control Plan (the "Plan"); and

         WHEREAS, pursuant to Section 8 of the Plan, the Company has the right
at any time to amend the Plan (except under certain circumstances set forth in
said Section 8 which are not applicable in the instant case); and

         WHEREAS, the Company now desires to amend the Plan;

         NOW, THEREFORE, the Plan is hereby amended, effective as of August 1,
2001, as follows:

         FIRST: Section 2.2(ii)(a)(II) of the Plan is hereby amended to read in
its entirety as follows:

                  "(II) any sale or series of sales since April 27, 2001
         involving an aggregate of fifty percent (50%) or more of the market
         value of Hanover's assets (for this purpose, said 50% amount shall be
         deemed to be $107.6 million); or"

         SECOND: Section 2.2 (ii)(B)(II) of the Plan is hereby amended to read
in its entirety as follows:

                  "(II) a Transaction (other than as described in clause
         (ii)(A)(II) of this definition) immediately following which the
         shareholders of Hanover immediately prior to the Transaction continue
         to have a majority of the voting power in the resulting entity."

         THIRD: Except to the extent hereinabove set forth, the Plan shall
remain in full force and effect without change or modification.
<PAGE>
         IN WITNESS WHEREOF, and as evidence of the adoption of the foregoing,
the Company has caused this Amendment Number 1 to be executed by a duly
authorized officer this 29th day of April, 2002.

                                        HANOVER DIRECT, INC.


                                        By: /s/ Charles F. Messina
                                           ------------------------------
                                        Name: Charles F. Messina
                                             ----------------------------
                                        Title: EVP/CAO
                                              ---------------------------

                                      -2-
EX-35.1
(logo) Bank of America

Bank of America
475 CrossPoint Parkway
PO Box 9000
Getzville, NY 14068-9000



Annual Statement as to Compliance
SAMI 2007-AR2


I, H. Randall Chestnut, Senior Vice President of Bank of America, N.A., (the
"Company"), hereby certify as pursuant to section 2.04 of the Servicing
Agreement between Bank of America, N.A., (the "Company") and EMC Mortgage
Corporation (the "Assignor") that; (i) a review of Bank of America, N.A.
activities during the 2007 year (or applicable portion thereof) and of its
performance under the Agreement and any applicable Reconstitution Agreement
during this period has been made under my supervision, and (ii) to the best of
my knowledge, based on such review, Bank of America, N.A. has fulfilled all of
its obligations under this Agreement and any applicable Reconstitution
Agreement in all material respects throughout the 2007 calendar year.


March 1, 2008


By: /s/ H. Randall Chestnut
Name: H. Randall Chestnut
Title: Senior Vice President
Exhibit 21

GREENWICH AIR SERVICES, INC.
Subsidiaries

GREENWICH AIR SERVICES - CONNECTICUT, INC.          Incorporated in Delaware
51 Bradley Park Road
P.O. box 1258
East Granby, Connecticut 06026

GREENWICH TURBINE TEST CORPORATION                  Incorporated in Delaware
215 East Hangar Road
John F. Kennedy International Airport
Jamaica, New York 11430

GREENWICH TURBINE INCORPORATED                      Incorporated in Delaware
51 Bradley Park Road
P.O. box 1258
East Granby, Connecticut 06026

GREENWICH FOREIGN SALES CORPORATION                 Incorporated in Barbados
CITCO Barbados, Limited,
Corporate Secretary
Alleyne House
White Park Road
Bridgetown, Barbados

GASI ENGINE SERVICES CORPORATION                    Incorporated in Delaware
P.O. Box 522187
Miami, Florida  33152

GREENWICH AIR SERVICES - TEXAS, LP                  Delaware Limited Partnership
9311 Reeves Street
Dallas, Texas 75235

MCALLEN COMPONENTS, LP                              Delaware Limited Partnership
Industrial Trade Zone
6200 South 42 Street
McAllen, Texas 78503

GREENWICH CALEDONIAN LIMITED                        Incorporated in Scotland
Prestwick International Airport
Prestwick, Ayshire, Scotland KA9 2RX

GREENWICH AIR SERVICES ASIA LTD.                    Incorporated in Hong Kong
Suite 1803, St George's Building
2 Ice House Street, Central
Hong Kong